<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The configuration of DNA at genetic loci that undergo somatic recombination in lymphocytes provides genetic markers that are useful in the diagnosis and characterization of non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The loci containing rearranged DNA fall into three groups: the immunoglobulin genes, the T cell receptor genes and sites of chromosomal rearrangements, such as chromosomal translocations </plain></SENT>
<SENT sid="2" pm="."><plain>DNA fragments cloned from these loci can be used as hybridization probes to characterize the rearranged DNA sequences in biopsy tissues </plain></SENT>
<SENT sid="3" pm="."><plain>Only probes for chromosomal rearrangements are capable of directly diagnosing <z:hpo ids='HP_0002664'>neoplasia</z:hpo> and histological subtypes; however, probes for rearrangements of immunoglobulin and T cell receptor genes are valuable for detecting clonal proliferations, determining B or T cell derivation of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> and distinguishing individual clones of lymphocytes from each other </plain></SENT>
<SENT sid="4" pm="."><plain>Applications of DNA rearrangements have already yielded a number of important findings concerning the biology of human <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>These discoveries have included the existence of multiclonal B cell <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, the widespread dissemination of occult <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> to lymph nodes in <z:e sem="disease" ids="C0026948" disease_type="Neoplastic Process" abbrv="">mycosis fungoides</z:e>, the high incidence of circulating <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells in patients with low grade <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and the molecular <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> of chromosomal break-points in follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
</text></document>